|Articles|March 1, 2012
- Pharmaceutical Executive-03-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - March 2012
Leading in Emerging Markets
Advertisement
Articles in this issue
about 14 years ago
Novartis: LEADing in Emerging Marketsabout 14 years ago
How Can We Fix the FDA?about 14 years ago
The Italian's Jobabout 14 years ago
Off the Hook? Pharm Exec's Annual Press Auditabout 14 years ago
The Maestrosabout 14 years ago
The (Life) Science of Digital Connectionsabout 14 years ago
Judging a Pill by its Coverabout 14 years ago
When Talk is Not So CheapNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5